Welcome to our dedicated page for Aramark US SEC filings (Ticker: ARMK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Aramark (ARMK) filings document a Delaware operating company with NYSE-listed common stock and a business centered on food, facilities management, hospitality, and support services. Its 8-K reports include operating results, material definitive agreements, annual meeting voting results, and compensation matters involving restricted stock units and executive equity awards.
Proxy materials disclose board elections, auditor ratification, executive compensation, equity awards, shareholder voting matters, and governance practices. Financing filings also describe amendments to the credit agreement of Aramark Services, Inc., an indirect wholly owned subsidiary, including term-loan refinancing and repricing transactions within the company’s capital structure.
Aramark reported a routine insider equity update for a director. On 12/17/2025, the reporting person received 96.688 shares of common stock as dividend equivalent rights tied to deferred stock units, at a stated price of $0 per share. These dividend equivalent rights vest on the same schedules as the underlying awards. After this transaction, the reporting person beneficially owned 30,513.088 shares of Aramark common stock in direct ownership.
Aramark reported a director-level insider transaction involving dividend equivalent rights on deferred stock units. On 12/17/2025, the reporting person acquired 75.633 shares of Aramark common stock at a price of $ 0, reflecting shares credited as dividend equivalents rather than an open-market purchase. Following this transaction, the insider beneficially owns 23,868.516 shares in direct form. The filing explains that these dividend equivalent rights arise from the issuer's quarterly dividend and vest on the same schedules as the underlying deferred stock unit awards.
Aramark director reported a small increase in their holdings of the company’s common stock through dividend-related awards. On 12/17/2025, the reporting person acquired 35.42 shares of common stock, recorded at a price of $0 per share, reflecting that this was an award rather than an open-market purchase.
After this transaction, the director beneficially owned 16,731.732 shares of Aramark common stock in direct ownership. The filing explains that these additional shares represent dividend equivalent rights, which are credited in connection with Aramark’s quarterly dividend on deferred stock units and vest on the same schedule as the underlying awards.
Aramark director reports additional stock from dividend equivalents. A director of Aramark reported receiving 255.993 shares of common stock on 12/17/2025, credited as dividend equivalent rights on deferred stock units. These rights arose from the company’s quarterly dividend and vest on the same schedule as the underlying deferred stock awards. Following this transaction, the director beneficially owns 94,298.114 Aramark common shares directly and 15,000 shares indirectly through a trust. The shares in this filing were acquired at a stated price of $0, reflecting a non-cash adjustment tied to existing compensation rather than an open-market purchase.
Aramark reported an insider equity change involving a company director. On 12/17/2025, the director acquired 136.134 shares of common stock at a price of $0. After this transaction, the director beneficially owned 42,961.657 shares of Aramark common stock in total.
According to the explanation, these additional shares represent dividend equivalent rights that accrued on deferred stock units the director already held, in connection with Aramark’s quarterly dividend. These dividend equivalent rights follow the same vesting schedule as the underlying deferred stock unit awards.
Aramark director reports automatic stock accrual from dividend equivalents. On 12/17/2025, a director of Aramark received 35.42 shares of common stock as dividend equivalent rights tied to the company’s quarterly dividend. These rights accrued on deferred stock units already held by the director and will vest on the same schedule as the underlying awards. The transaction was recorded at a price of $0, reflecting that it was an automatic dividend-related accrual rather than an open-market purchase. Following this transaction, the director beneficially owned 11,177.732 shares of Aramark common stock in direct ownership.
Aramark reported a routine insider ownership update. A director acquired 24.894 shares of common stock on 12/17/2025, reported with transaction code "A" for an acquisition. The shares were credited at a price of $0 as dividend equivalent rights tied to the company’s quarterly dividend on deferred stock units held by the director.
After this transaction, the director directly beneficially owned 7,991.184 shares of Aramark common stock. The dividend equivalent rights vest on the same schedule as the underlying deferred stock unit awards.
Aramark director reports dividend-equivalent stock units
A director of Aramark (ARMK) reported an automatic grant of 75.633 shares of common stock on 12/17/2025. The transaction was recorded at a price of $0 per share, reflecting dividend equivalent rights credited on deferred stock units the director already holds. After this grant, the director beneficially owns a total of 23,868.516 shares of Aramark common stock in direct ownership form. The filing notes that these dividend equivalent rights vest on the same schedule as the underlying deferred stock unit awards.
Aramark, through its subsidiary Aramark Services, Inc., entered into Amendment No. 19 to its Credit Agreement to reprice its U.S. term debt. The company refinanced all outstanding U.S. Term B-8 Loans with new U.S. Term B-10 Loans totaling $2,384,140,862.90, maturing in June 2030, fully funded on December 11, 2025 and used to repay the prior tranche.
The new Term B-10 Loans bear interest at the company’s option at Term SOFR plus an initial margin of 1.75% or a base rate plus an initial margin of 0.75%. Principal repayments of $6,290,609.14 are required quarterly from December 31, 2028 through March 31, 2030, and the loans remain subject to substantially similar guarantees, collateral, prepayment provisions and covenants as the previous Term B-8 Loans.
Aramark executive reports routine share withholding for taxes. An Aramark executive, serving as EVP and General Counsel, reported a transaction dated 12/02/2025 under Form 4. The filing shows that 985.096 shares of Aramark common stock were disposed of at $37.08 per share, not as an open-market sale but as shares withheld to cover taxes due on the vesting of restricted stock units. After this tax withholding, the executive beneficially owns 126,555.691 shares of Aramark common stock in direct ownership. The transaction reflects standard equity compensation and tax treatment rather than a discretionary sale.